BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 14994336)

  • 1. Binding and transport of [3H](2S,4R)- 4-methylglutamate, a new ligand for glutamate transporters, demonstrate labeling of EAAT1 in cultured murine astrocytes.
    Apricò K; Beart PM; Crawford D; O'Shea RD
    J Neurosci Res; 2004 Mar; 75(6):751-9. PubMed ID: 14994336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of [(3)H]-(2S,4R)-4-methylglutamate and [(3)H]D-aspartate as ligands for binding and autoradiographic analyses of glutamate transporters.
    Apricò K; Beart PM; Crawford D; O'shea RD
    Neurochem Int; 2007 Dec; 51(8):507-16. PubMed ID: 17590480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [(3)H](2S,4R)-4-Methylglutamate: a novel ligand for the characterization of glutamate transporters.
    Apricó K; Beart PM; Lawrence AJ; Crawford D; O'Shea RD
    J Neurochem; 2001 Jun; 77(5):1218-25. PubMed ID: 11389172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of (2S, 3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA) on the astrocytic sodium responses to glutamate.
    Bozzo L; Chatton JY
    Brain Res; 2010 Feb; 1316():27-34. PubMed ID: 20026319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Links between L-glutamate transporters, Na+/K+-ATPase and cytoskeleton in astrocytes: evidence following inhibition with rottlerin.
    Sheean RK; Lau CL; Shin YS; O'Shea RD; Beart PM
    Neuroscience; 2013 Dec; 254():335-46. PubMed ID: 24095695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters.
    Shimamoto K; Otsubo Y; Shigeri Y; Yasuda-Kamatani Y; Satoh M; Kaneko S; Nakagawa T
    Mol Pharmacol; 2007 Jan; 71(1):294-302. PubMed ID: 17047096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of glutamate transport substrates and glutamate receptor ligands on the activity of Na-/K(+)-ATPase in brain tissue in vitro.
    Nanitsos EK; Acosta GB; Saihara Y; Stanton D; Liao LP; Shin JW; Rae C; Balcar VJ
    Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):762-9. PubMed ID: 15566390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabotropic glutamate receptor agonists reduce glutamate release from cultured astrocytes.
    Ye ZC; Sontheimer H
    Glia; 1999 Feb; 25(3):270-81. PubMed ID: 9932873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitatory amino acid transporter expression by astrocytes is neuroprotective against microglial excitotoxicity.
    Liang J; Takeuchi H; Doi Y; Kawanokuchi J; Sonobe Y; Jin S; Yawata I; Li H; Yasuoka S; Mizuno T; Suzumura A
    Brain Res; 2008 May; 1210():11-9. PubMed ID: 18410911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate transporter expression and function in human glial progenitors.
    Maragakis NJ; Dietrich J; Wong V; Xue H; Mayer-Proschel M; Rao MS; Rothstein JD
    Glia; 2004 Jan; 45(2):133-43. PubMed ID: 14730707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay.
    Jensen AA; Bräuner-Osborne H
    Biochem Pharmacol; 2004 Jun; 67(11):2115-27. PubMed ID: 15135308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal glutamate transporter EAAT4 is expressed in astrocytes.
    Hu WH; Walters WM; Xia XM; Karmally SA; Bethea JR
    Glia; 2003 Oct; 44(1):13-25. PubMed ID: 12951653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of astroglial glutamate transport by polyunsaturated fatty acids: evidence for a signalling role of docosahexaenoic acid.
    Grintal B; Champeil-Potokar G; Lavialle M; Vancassel S; Breton S; Denis I
    Neurochem Int; 2009 Jul; 54(8):535-43. PubMed ID: 19428799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glutamate transporter and receptor ligands on neuronal glutamate uptake.
    Boeck CR; Kroth EH; Bronzatto MJ; Jardim FM; Souza DO; Vendite D
    Neurosci Res; 2005 Sep; 53(1):77-83. PubMed ID: 16011854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking.
    Hughes EG; Maguire JL; McMinn MT; Scholz RE; Sutherland ML
    Brain Res Mol Brain Res; 2004 May; 124(2):114-23. PubMed ID: 15135219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate leakage from a compartmentalized intracellular metabolic pool and activation of the lipoxygenase pathway mediate oxidative astrocyte death by reversed glutamate transport.
    Re DB; Nafia I; Melon C; Shimamoto K; Kerkerian-Le Goff L; Had-Aissouni L
    Glia; 2006 Jul; 54(1):47-57. PubMed ID: 16673373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings.
    Suchak SK; Baloyianni NV; Perkinton MS; Williams RJ; Meldrum BS; Rattray M
    J Neurochem; 2003 Feb; 84(3):522-32. PubMed ID: 12558972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive astrocytes and activated microglial cells express EAAT1, but not EAAT2, reflecting a neuroprotective potential following ischaemia.
    Beschorner R; Simon P; Schauer N; Mittelbronn M; Schluesener HJ; Trautmann K; Dietz K; Meyermann R
    Histopathology; 2007 Jun; 50(7):897-910. PubMed ID: 17543080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative and excitotoxic insults exert differential effects on spinal motoneurons and astrocytic glutamate transporters: Implications for the role of astrogliosis in amyotrophic lateral sclerosis.
    Zagami CJ; Beart PM; Wallis N; Nagley P; O'Shea RD
    Glia; 2009 Jan; 57(2):119-35. PubMed ID: 18661557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lipopolysaccharide on glial phenotype and activity of glutamate transporters: Evidence for delayed up-regulation and redistribution of GLT-1.
    O'Shea RD; Lau CL; Farso MC; Diwakarla S; Zagami CJ; Svendsen BB; Feeney SJ; Callaway JK; Jones NM; Pow DV; Danbolt NC; Jarrott B; Beart PM
    Neurochem Int; 2006; 48(6-7):604-10. PubMed ID: 16530295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.